Basic Information
| LncRNA/CircRNA Name | lncRNA-n326322 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | nasopharyngeal cancer |
| ICD-0-3 | C11 |
| Methods | qPCR, Western blot |
| Sample | cell lines (NP69, NPC, CNE1, CNE2, 5-8F, 6-10B) |
| Expression Pattern | up-regulated |
| Function Description | the overexpression of lncRNA-n326322 promoted NPC cell proliferation and invasion, whereas the downregulation of lncRNA-n326322 suppressed cell proliferation and invasion. potential mechanism may be associated with the activation of PI3K/AKT and ERK/MAPK pathways.lncRNA-n326322 is associated with tumorigenesis of NPC. |
| Pubmed ID | 29416735 |
| Year | 2017 |
| Title | Long non-coding RNA n326322 promotes the proliferation and invasion in nasopharyngeal carcinoma. |
External Links
| Links for lncRNA-n326322 | GenBank HGNC NONCODE |
| Links for nasopharyngeal cancer | OMIM COSMIC |